Pasithea Therapeutics Corp. (NASDAQ:KTTA) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock (or pre-funded warrants in lieu thereof) Closed: US$60M raised · US$0.75 a share · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Buyers: Vivo Capital; Janus Henderson Investors; Coastlands Capital; Columbia Threadneedle Investments; Adage Capital Partners; Squadron Capital Management Use of proceeds: General corporate purposes, including research, clinical trials and working capital | Dec 2, 2025 |
| Public offering of common stock (or pre-funded warrants) with Series C and Series D warrants Closed: US$5M raised · US$1.4 a share · Warrants at US$1.4 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: General corporate purposes, including research, pre-clinical studies, clinical trials, licensing, acquisitions and working capital | May 7, 2025 |
| Warrant exercise of series D warrants Closed: US$1.3M raised · US$1.4 a share | May 7, 2025 |